Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study of Duffy-null Associated Absolute Neutropenia and Its Impact on Chemotherapy Dosing

NCT07743086 is registered in ClinicalTrials.gov with Barbara Ann Karmanos Cancer Institute as lead sponsor.

NCT NCT07743086
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07743086 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study of Duffy-null Associated Absolute Neutropenia and Its Impact on Chemotherapy Dosing
Lead sponsor
Barbara Ann Karmanos Cancer Institute
Phase
Phase 1/2
Overall status
Not yet recruiting
Start date
September 30, 2026
Completion date
April 30, 2029
Enrollment
886 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumor cancer